Global and Region Influenza Drugs and Vaccines Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Influenza Drugs and Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Influenza Drugs and Vaccinesmarket, defines the market attractiveness level of Influenza Drugs and Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Influenza Drugs and Vaccines industry, describes the types of Influenza Drugs and Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Influenza Drugs and Vaccines market and the development prospects and opportunities of Influenza Drugs and Vaccines industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Influenza Drugs and Vaccines market in Chapter 13.

    By Player:

    • ABPI

    • Astrazeneca

    • Protein Sciences Corporation

    • Emergent Biosolutions

    • GlaxoSmithKline

    • Sanofi Pasteur, Inc

    • Serum Institute Of India Pvt Ltd

    • Alvogen

    • BioCryst PharmaceuticalsInc

    • CSL Limited

    By Type:

    • Zanamivir

    • Oseltamivir Phosphate

    • Peramivir

    • Trivalent

    • Quadrivalent

    By End-User:

    • Hospitals

    • Research Laboratories

    • Pharmacies

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Influenza Drugs and Vaccines Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Influenza Drugs and Vaccines Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Influenza Drugs and Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Influenza Drugs and Vaccines Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Influenza Drugs and Vaccines Market Analysis and Outlook to 2022

    • 7.1 Global Influenza Drugs and Vaccines Consumption (2017-2022)

    • 7.2 United States Influenza Drugs and Vaccines Consumption (2017-2022)

    • 7.3 Europe Influenza Drugs and Vaccines Consumption (2017-2022)

    • 7.4 China Influenza Drugs and Vaccines Consumption (2017-2022)

    • 7.5 Japan Influenza Drugs and Vaccines Consumption (2017-2022)

    • 7.6 India Influenza Drugs and Vaccines Consumption (2017-2022)

    • 7.7 South Korea Influenza Drugs and Vaccines Consumption (2017-2022)

    8 Region and Country-wise Influenza Drugs and Vaccines Market Analysis and Outlook to 2028

    • 8.1 Global Influenza Drugs and Vaccines Consumption Forecast (2022-2028)

    • 8.2 United States Influenza Drugs and Vaccines Consumption Forecast (2022-2028)

    • 8.3 Europe Influenza Drugs and Vaccines Consumption Forecast (2022-2028)

    • 8.4 China Influenza Drugs and Vaccines Consumption Forecast (2022-2028)

    • 8.5 Japan Influenza Drugs and Vaccines Consumption Forecast (2022-2028)

    • 8.6 India Influenza Drugs and Vaccines Consumption Forecast (2022-2028)

    • 8.7 South Korea Influenza Drugs and Vaccines Consumption Forecast (2022-2028)

    9 Global Influenza Drugs and Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Influenza Drugs and Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Zanamivir Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Oseltamivir Phosphate Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Peramivir Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Trivalent Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Quadrivalent Consumption and Growth Rate (2017-2022)

    • 9.2 Global Influenza Drugs and Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Research Laboratories Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Influenza Drugs and Vaccines Market Outlook by Types and Applications to 2028

    • 10.1 Global Influenza Drugs and Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Zanamivir Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Oseltamivir Phosphate Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Peramivir Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Trivalent Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Quadrivalent Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Influenza Drugs and Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Research Laboratories Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Influenza Drugs and Vaccines Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Influenza Drugs and Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Influenza Drugs and Vaccines Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Influenza Drugs and Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Influenza Drugs and Vaccines Market Competitive Analysis

    • 14.1 ABPI

      • 14.1.1 ABPI Company Details

      • 14.1.2 ABPI Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 ABPI Influenza Drugs and Vaccines Product and Service

    • 14.2 Astrazeneca

      • 14.2.1 Astrazeneca Company Details

      • 14.2.2 Astrazeneca Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Astrazeneca Influenza Drugs and Vaccines Product and Service

    • 14.3 Protein Sciences Corporation

      • 14.3.1 Protein Sciences Corporation Company Details

      • 14.3.2 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Protein Sciences Corporation Influenza Drugs and Vaccines Product and Service

    • 14.4 Emergent Biosolutions

      • 14.4.1 Emergent Biosolutions Company Details

      • 14.4.2 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Emergent Biosolutions Influenza Drugs and Vaccines Product and Service

    • 14.5 GlaxoSmithKline

      • 14.5.1 GlaxoSmithKline Company Details

      • 14.5.2 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GlaxoSmithKline Influenza Drugs and Vaccines Product and Service

    • 14.6 Sanofi Pasteur, Inc

      • 14.6.1 Sanofi Pasteur, Inc Company Details

      • 14.6.2 Sanofi Pasteur, Inc Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Sanofi Pasteur, Inc Influenza Drugs and Vaccines Product and Service

    • 14.7 Serum Institute Of India Pvt Ltd

      • 14.7.1 Serum Institute Of India Pvt Ltd Company Details

      • 14.7.2 Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Product and Service

    • 14.8 Alvogen

      • 14.8.1 Alvogen Company Details

      • 14.8.2 Alvogen Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Alvogen Influenza Drugs and Vaccines Product and Service

    • 14.9 BioCryst PharmaceuticalsInc

      • 14.9.1 BioCryst PharmaceuticalsInc Company Details

      • 14.9.2 BioCryst PharmaceuticalsInc Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 BioCryst PharmaceuticalsInc Influenza Drugs and Vaccines Product and Service

    • 14.10 CSL Limited

      • 14.10.1 CSL Limited Company Details

      • 14.10.2 CSL Limited Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 CSL Limited Influenza Drugs and Vaccines Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Influenza Drugs and Vaccines

    • Figure Influenza Drugs and Vaccines Picture

    • Table Global Influenza Drugs and Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Influenza Drugs and Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Influenza Drugs and Vaccines Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Influenza Drugs and Vaccines Consumption by Country (2017-2022)

    • Figure United States Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure China Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza Drugs and Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Zanamivir Consumption and Growth Rate (2017-2022)

    • Figure Global Oseltamivir Phosphate Consumption and Growth Rate (2017-2022)

    • Figure Global Peramivir Consumption and Growth Rate (2017-2022)

    • Figure Global Trivalent Consumption and Growth Rate (2017-2022)

    • Figure Global Quadrivalent Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Research Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Zanamivir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oseltamivir Phosphate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Peramivir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Trivalent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Quadrivalent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Influenza Drugs and Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Influenza Drugs and Vaccines Export by Region (Top 5 Countries) (2017-2028)

    • Table ABPI (Foundation Year, Company Profile and etc.)

    • Table ABPI Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table ABPI Influenza Drugs and Vaccines Product and Service

    • Table Astrazeneca (Foundation Year, Company Profile and etc.)

    • Table Astrazeneca Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astrazeneca Influenza Drugs and Vaccines Product and Service

    • Table Protein Sciences Corporation (Foundation Year, Company Profile and etc.)

    • Table Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Protein Sciences Corporation Influenza Drugs and Vaccines Product and Service

    • Table Emergent Biosolutions (Foundation Year, Company Profile and etc.)

    • Table Emergent Biosolutions Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent Biosolutions Influenza Drugs and Vaccines Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Influenza Drugs and Vaccines Product and Service

    • Table Sanofi Pasteur, Inc (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur, Inc Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur, Inc Influenza Drugs and Vaccines Product and Service

    • Table Serum Institute Of India Pvt Ltd (Foundation Year, Company Profile and etc.)

    • Table Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Product and Service

    • Table Alvogen (Foundation Year, Company Profile and etc.)

    • Table Alvogen Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alvogen Influenza Drugs and Vaccines Product and Service

    • Table BioCryst PharmaceuticalsInc (Foundation Year, Company Profile and etc.)

    • Table BioCryst PharmaceuticalsInc Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioCryst PharmaceuticalsInc Influenza Drugs and Vaccines Product and Service

    • Table CSL Limited (Foundation Year, Company Profile and etc.)

    • Table CSL Limited Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Limited Influenza Drugs and Vaccines Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.